Skip to content
Home
Who We Are
About Us
Team
Advisory Board
Partners
What We Do
AMR Diagnostics
AMRx®
AMR Therapeutics
AMR Lab
How We Work
Drug Discovery Platforms
AMRx® De novo
AMRx® Drug Repurposing
Patents
Blog
Contact us
Home
Who We Are
About Us
Team
Advisory Board
Partners
What We Do
AMR Diagnostics
AMRx®
AMR Therapeutics
AMR Lab
How We Work
Drug Discovery Platforms
AMRx® De novo
AMRx® Drug Repurposing
Patents
Blog
Contact us
February 23, 2026
Hyderabad-based startup to begin human clinical trials for India’s first AI-driven antibiotic
Prev
Previous
SCIINV Develops first AI-driven anti-microbial candidate
Next
Pioneering the Fight Against AMR: The Rise of SCIINV Biosciences
Next
